The Bone Metabolism Characteristics of Premature Ovarian Insufficiency
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-39
SponsorShi Yun
About this trial
Explore the bone metabolism characteristics of premature ovarian insufficiency.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial population
females with premature ovarian insufficiency
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Testing the serum levels of bone metabolic markers
Diagnostic testTesting serum levels of TRACP-5b and BALP, BMD values of lumbar spine L1-L4, left and right hip, left and right femoral neck et.al.
Treatment groups
60 Participants
are divided into 1 treatment groupGroup A: POI Group1 intervention
Trial outcomes
Primary outcomes
1
tartrate resistant acid phosphatase-5b, TRACP-5b
Blood samples are collected when enrolled.
Time frame
On the 2~4th day of menstruation (amenorrhea patients are collected when enrolled)Secondary outcomes
1
bone specific alkaline phosphatase, BALP
Blood samples are collected when enrolled.
Time frame
On the 2~4th day of menstruation (amenorrhea patients are collected when enrolled)2
bone mineral density, BMD
BMD values of lumbar spine L1-L4, left and right hip, left and right femoral neck
Time frame
On the 2~4th day of menstruation (amenorrhea patients are collected when enrolled)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Shi Yun
Lead sponsor
Dongzhimen Hospital, Beijing
Sponsor institution
Source ClinicalTrials.gov